Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Daily Market Comment – Euro flatlines but stocks lifted by vaccine and stimulus progress



  • EU strikes compromise deal on a virus recovery fund but euro pares gains
  • Positive vaccine headlines drive Nasdaq to record close as key earnings loom
  • Win-win situation for gold as it climbs to 9-year highs
  • Focus turns to talks on US fiscal package and Brexit; dollar sags but pound upbeat

Europe gets its fiscal bazooka; euro pauses for breath

European Union leaders ended a marathon summit on Tuesday with a classic fudge as a compromise deal that significantly waters down the original plan of a €750 billion rescue package finally got the backing of the ‘frugal’ nations. Under the agreement, €360 bln will be disbursed as loans, but only €390 bln will be allocated as grants, down from the initial proposal of €500 bln.

After hitting fresh 4-month highs earlier today, the euro became the victim of ‘buy the rumour, sell the fact’, falling on the announcement, but has since picked up some momentum again to trade nearer $1.1450.

European stocks cheered the much-anticipated fiscal boost for the euro area economy, which has been devastated by the Covid-19 pandemic. Germany’s DAX index soared to the highest since late February, pulling the Euro Stoxx 50 index to a 4½-month peak.

Vaccine and stimulus hopes re-energize Nasdaq

Global shares were also riding high on Tuesday, lifted by the stimulus news not just in Europe but elsewhere too. The Australian government has extended its wage subsidy scheme until March 2021, while in the United States, White House officials are in talks with the Democrats to reach an agreement on a new virus support package.

Adding to the positive sentiment were encouraging headlines for two separate coronavirus vaccines being tested by AstraZeneca and Pfizer. The companies’ latest trial results indicate it’s so far so good for developing a successful vaccine, though the timeline for when they can become commercially available is still unclear. Progress is also being made on a treatment for the virus, with British biotech firm, Synairgen, yesterday saying its drug can reduce severe cases from developing in patients by 79%.

All this buoyed Wall Street to fresh highs, sending the Nasdaq Composite and Nasdaq 100 to a record close as tech stocks regained their mojo, having underperformed in recent days. The S&P 500 hit a 5-month high but the Dow Jones lagged amid some caution for traditional stocks as the earnings releases pick up pace this week. Coca-Cola and United Airlines are due to report their results later today and e-mini futures were pointing to a higher open.

Virus risks and stimulus a boon for gold

With the recent bouts of risk-off proving short-lived, it seems there’s little that can get in the way of the underlying optimism in the markets, which is being fed by expectations that governments and central banks will keep the cheap liquidity flowing for as long as needed. However, the next round of fiscal stimulus in the US could prove trickier than the previous relief bills as both the Republicans and Democrats will have the November presidential election in mind when making their demands.

But time is short and with the negotiations coinciding with the earnings season, the next couple of weeks could be quite bumpy for Wall Street.

In the meantime, the only way is up for gold as the precious metal has not only been benefiting from the recent resurgence of virus cases around the world but also from the super-low government bond yields that look set to stay low even if the global economic recovery doesn’t falter.

Gold has broken above the $1,820/oz level to reach the highest in almost nine years.

Dollar hits 4-month low; pound eyes Brexit talks

An additional source of support for the gold rally has been a weakening greenback. The dollar index slid to 4-month lows earlier today, weighed down not just by a stronger euro but also from a perked-up pound.

Sterling is flirting with the $1.27 handle for the first time since mid-June on hopes that the latest round of Brexit negotiations taking place in London this week will bear some fruit. However, a deal remains far off given the significant differences on several issues and the pound could just be setting itself up for a big fall.

The Australian dollar was another star performer on Tuesday, climbing back above the $0.70 level despite the risk to Australia’s economy from the lockdown in Victoria. The aussie’s bull run was given the green light by RBA Governor Philip Lowe who has yet to express his displeasure at the exchange rate, saying it’s “hard to argue” that the currency is overvalued when speaking earlier today.


Pinakabagong Balita

Technical Analysis – EURUSD returns to its bullish race

E

E

Was the recent stock market slump an overreaction? – Stock Markets

U
U
U

Technical Analysis – Is gold ready to sail to an all-time high?

G

E

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.